Exercise for Depression: How Strong Is the Evidence Really?

A large 2024 network meta-analysis in The BMJ pooled 218 randomised trials and more than 14,000 people, and its headline is genuinely encouraging: exercise reduced depressive symptoms, with the biggest effects for dance and for walking or jogging, and yoga and strength training close behind. The honest footnote matters just as much. The authors rated their confidence in most of these findings as low or very low, only one trial in the entire set met strict criteria for low risk of bias, and you cannot give someone a placebo version of a jog. The fair reading is that exercise is a well-supported addition to depression care, not a proven swap for therapy or medication.

What the 2024 analysis actually found

Michael Noetel and colleagues published their systematic review and network meta-analysis in The BMJ in February 2024. They combined 218 unique studies (495 treatment arms, 14,170 participants) and used network methods, which allow treatments that were never tested head to head to be compared by borrowing strength across the whole web of trials. Compared with active control conditions such as usual care, the largest symptom reduction was for dance (a large effect), followed by moderate reductions for walking or jogging, yoga, strength training, mixed aerobic exercise, and tai chi or qigong. More vigorous activity tended to help more. When the authors looked at who stayed with the program, strength training and yoga had the lowest dropout.

Those effect sizes are not trivial. The moderate-to-large range reported here sits in the same neighbourhood as the medium effect (a standardised reduction of roughly 0.43) that an earlier umbrella review in the British Journal of Sports Medicine found across dozens of physical-activity reviews, an effect the authors described as comparable to psychotherapy and medication. Two independent bodies of evidence pointing the same direction is a real signal.

Why the rankings carry an asterisk

Here is where careful reading earns its keep. The authors themselves flagged that only one study met the Cochrane criteria for low risk of bias, and that their formal confidence (using CINeMA, the network version of the GRADE approach) was low for walking or jogging and very low for the other modalities. Low confidence does not mean the finding is wrong. It means the true effect could be meaningfully different from the reported estimate, and that new high-quality trials could shift it.

The deepest problem is blinding. In a drug trial you can give the comparison group an identical-looking placebo pill, so neither the patient nor, often, the person scoring symptoms knows who received the active treatment. You cannot do that with exercise. People know whether they have been jogging three times a week, and that knowledge carries expectation, attention, and the ordinary lift of having somewhere to be and something to finish. Part of what these trials capture is the specific biological and psychological effect of movement; part is the expectancy that rides along with any energetic, structured intervention. Comparing exercise against an active control rather than a do-nothing waitlist, as this analysis did, tightens the comparison, but it does not fully separate the two.

A related caution applies to the eye-catching subgroup results, such as strength training appearing to help women more and yoga appearing to help men and older adults more. Those come from splitting the data into smaller slices, and subgroup findings are best treated as hypotheses for future trials, not as prescriptions. Very few of the included studies followed people for a year or more, so how long the benefit lasts is largely unknown.

What "adjunct" really means

Calling exercise an adjunct is not a hedge; it is a precise description of what was tested. Most of these trials added exercise to whatever care people were already receiving, or compared it against usual care, rather than pitting it against a fully dosed course of medication or therapy in people with severe illness. That design supports a specific claim: adding structured activity tends to improve symptoms. It does not support telling someone with severe or high-risk depression to stop an effective treatment and rely on movement alone.

For milder symptoms, the case for making exercise a first-line ingredient is reasonable and is already reflected in some clinical guidance. For moderate to severe depression, the sensible framing is exercise alongside evidence-based care, with the choice of modality driven less by the leaderboard and more by what a given person will actually keep doing. An intervention only works if it is done, which is why the tolerability data (yoga and strength training keeping people engaged) may matter more in practice than which modality topped the efficacy chart.

How to read a headline like this

"Dance beats antidepressants" is the kind of headline this study invited and does not earn. The stronger, duller truth is that a big, well-conducted synthesis found consistent benefit from several kinds of exercise, that its authors were unusually candid about their own low confidence, and that the inability to blind participants keeps a ceiling on certainty. That combination is a reason to move more, not a reason to abandon treatments that rest on sturdier evidence. When you meet the next confident claim built on the same dataset, the useful questions are what it was compared against, whether anyone could have been blinded, and how much the authors trusted their own numbers. Reading the evidence well means holding the encouragement and the caveat at once. This article is educational and is not medical advice.